David Feldman

30.8k total citations · 5 hit papers
350 papers, 23.1k citations indexed

About

David Feldman is a scholar working on Pathology and Forensic Medicine, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, David Feldman has authored 350 papers receiving a total of 23.1k indexed citations (citations by other indexed papers that have themselves been cited), including 169 papers in Pathology and Forensic Medicine, 120 papers in Genetics and 88 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in David Feldman's work include Vitamin D Research Studies (164 papers), Estrogen and related hormone effects (108 papers) and Biotin and Related Studies (36 papers). David Feldman is often cited by papers focused on Vitamin D Research Studies (164 papers), Estrogen and related hormone effects (108 papers) and Biotin and Related Studies (36 papers). David Feldman collaborates with scholars based in United States, France and Belgium. David Feldman's co-authors include Aruna V. Krishnan, Brian J. Feldman, Peter J. Malloy, Srilatha Swami, Donna M. Peehl, Theresa L. Chen, John W. Funder, David S. Loose, Isidore S. Edelman and Coleman Gross and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

David Feldman

344 papers receiving 22.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The development of androgen-independent prostate cancer

2001 1.9k citations Brian J. Feldman, David Feldman Nature reviews. Cancer profile →
The role of vitamin D in reducing cancer risk and progression

2014 989 citations David Feldman, Aruna V. Krishnan et al. Nature reviews. Cancer profile →
1,25-DIHYDROXYVITAMIN D₃AND MALIGNANT MELANOMA: THE PRESENCE OF RECEPTORS AND INHIBITION OF CELL GROWTH IN CULTURE

1981 452 citations David Feldman et al. Endocrinology profile →
Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes.

1983 363 citations David Feldman et al. Journal of Clinical Investigation profile →
Consensus statement from 2nd International Conference on Controversies in Vitamin D

2020 190 citations David Feldman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Feldman United States	82	9.7k	6.4k	5.8k	5.0k	3.5k	350	23.1k
John D. Potter United States	113	10.1k 1.0×	14.5k 2.2×	7.0k 1.2×	2.4k 0.5×	3.4k 1.0×	681	50.3k
Laurence N. Kolonel United States	90	4.1k 0.4×	6.1k 0.9×	5.8k 1.0×	3.1k 0.6×	3.7k 1.1×	435	28.6k
James T. Willerson United States	101	2.4k 0.2×	9.3k 1.4×	1.5k 0.3×	4.0k 0.8×	4.0k 1.2×	631	47.8k
Kiyoshi Kurokawa Japan	75	2.5k 0.3×	5.2k 0.8×	1.8k 0.3×	2.5k 0.5×	2.3k 0.7×	522	22.6k
Malcolm C. Pike United States	92	4.2k 0.4×	5.7k 0.9×	7.4k 1.3×	2.9k 0.6×	4.2k 1.2×	403	33.2k
Takashi Kadowaki Japan	119	2.0k 0.2×	25.1k 3.9×	5.3k 0.9×	14.1k 2.8×	1.8k 0.5×	869	62.0k
Nicholas Day United Kingdom	90	3.1k 0.3×	2.6k 0.4×	2.6k 0.4×	2.3k 0.5×	3.0k 0.9×	270	26.8k
David J. Gordon United States	73	1.4k 0.1×	7.6k 1.2×	2.1k 0.4×	8.5k 1.7×	2.5k 0.7×	231	32.8k
Göran K. Hansson Sweden	101	1.5k 0.2×	14.0k 2.2×	1.8k 0.3×	2.8k 0.5×	3.5k 1.0×	455	53.2k
Scott L. Friedman United States	119	4.2k 0.4×	18.1k 2.8×	2.7k 0.5×	4.9k 1.0×	2.9k 0.8×	438	61.8k

Countries citing papers authored by David Feldman

Since Specialization

Citations

This map shows the geographic impact of David Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Feldman more than expected).

Fields of papers citing papers by David Feldman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Feldman. The network helps show where David Feldman may publish in the future.

Co-authorship network of co-authors of David Feldman

This figure shows the co-authorship network connecting the top 25 collaborators of David Feldman. A scholar is included among the top collaborators of David Feldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Feldman. David Feldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blumenthal, Roger S., et al.. (2025). High-sensitivity C-reactive Protein in Atherosclerotic Cardiovascular Disease: To Measure or Not to Measure?. US Cardiology Review. 19. e06–e06. 4 indexed citations

Feldman, David, et al.. (2024). Leveraging Remote Patient Monitoring to Effectively Put the Heart Failure Guidelines to Practice. Journal of Cardiac Failure. 30(9). 1166–1169. 2 indexed citations

Feldman, David, et al.. (2023). Abstract 14872: A Nationwide Telehealth Heart Failure Program: Can Remote Patient Monitoring and Guideline Directed Treatment Protocols Benefit HFpEF Management?. Circulation. 148(Suppl_1). 1 indexed citations

Peng, Cheng, Yujing J. Heng, Donghao Lu, et al.. (2020). Prediagnostic 25-Hydroxyvitamin D Concentrations in Relation to Tumor Molecular Alterations and Risk of Breast Cancer Recurrence. Cancer Epidemiology Biomarkers & Prevention. 29(6). 1253–1263. 8 indexed citations

Tanaka, Yoshihiro, Joshua D. Bundy, Norrina B. Allen, et al.. (2019). Association of Erectile Dysfunction with Incident Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis (MESA). The American Journal of Medicine. 133(5). 613–620.e1. 11 indexed citations

Uddin, S.M. Iftekhar, Mohammadhassan Mirbolouk, Kevin L. Billups, et al.. (2017). Vascular Erectile Dysfunction and Subclinical Cardiovascular Disease. Current Sexual Health Reports. 9(4). 305–312. 13 indexed citations

Jeong, Youngtae, Srilatha Swami, Aruna V. Krishnan, et al.. (2015). Inhibition of Mouse Breast Tumor-Initiating Cells by Calcitriol and Dietary Vitamin D. Molecular Cancer Therapeutics. 14(8). 1951–1961. 46 indexed citations

Malloy, Peter J., Velibor Tasić, Doris Taha, et al.. (2013). Vitamin D receptor mutations in patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets. Molecular Genetics and Metabolism. 111(1). 33–40. 39 indexed citations

Mazower, Mark, Jessica Reinisch, & David Feldman. (2011). Post-war reconstruction in Europe : international perspectives, 1945-1949. Oxford University Press eBooks. 13 indexed citations

10.

Malloy, Peter J., Yulin Zhou, Jining Wang, Olaf Hiort, & David Feldman. (2011). Hereditary vitamin D–resistant rickets (HVDRR) owing to a heterozygous mutation in the vitamin D receptor. Journal of Bone and Mineral Research. 26(11). 2710–2718. 28 indexed citations

11.

Mason, Rebecca S., Vanessa B. Sequeira, Katie M. Dixon, et al.. (2010). Photoprotection by 1α,25-dihydroxyvitamin D and analogs: Further studies on mechanisms and implications for UV-damage. The Journal of Steroid Biochemistry and Molecular Biology. 121(1-2). 164–168. 58 indexed citations

12.

Srinivas, Sandy & David Feldman. (2009). A phase II trial of calcitriol and naproxen in recurrent prostate cancer.. PubMed. 29(9). 3605–10. 53 indexed citations

13.

Peng, Lihong, Jining Wang, Peter J. Malloy, & David Feldman. (2007). The role of insulin‐like growth factor binding protein‐3 in the growth inhibitory actions of androgens in LNCaP human prostate cancer cells. International Journal of Cancer. 122(3). 558–566. 20 indexed citations

14.

Peehl, Donna M. & David Feldman. (2004). Interaction of nuclear receptor ligands with the Vitamin D signaling pathway in prostate cancer. The Journal of Steroid Biochemistry and Molecular Biology. 92(4). 307–315. 31 indexed citations

15.

Feldman, Brian J. & David Feldman. (2001). The development of androgen-independent prostate cancer. Nature reviews. Cancer. 1(1). 34–45. 1887 indexed citations breakdown →

16.

Mark, H.F.L., et al.. (1999). HER-2/neu Oncogene Amplification in Cervical Cancer Studied by Fluorescent In Situ Hybridization. Genetic Testing. 3(2). 237–242. 16 indexed citations

17.

Sarabia, Stephen F., et al.. (1999). PPARγ Agonists Enhance Human Vascular Endothelial Adhesiveness by Increasing ICAM-1 Expression. Biochemical and Biophysical Research Communications. 263(3). 718–722. 40 indexed citations

18.

Mark, Hon Fong L., David Feldman, & Mark Sigman. (1999). Conventional and Molecular Cytogenetic Identification of a Variant Klinefelter Syndrome Patient with a Deleted X Chromosome. Pathobiology. 67(1). 55–58. 6 indexed citations

19.

Malloy, P J, Ze’ev Hochberg, Dov Tiosano, et al.. (1990). The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families.. Journal of Clinical Investigation. 86(6). 2071–2079. 129 indexed citations

20.

Bruns, David E., Aruna V. Krishnan, David Feldman, et al.. (1989). Epidermal Growth Factor Increases Intestinal Calbindin-D_9kand 1,25-Dihydroxyvitamin D Receptors in Neonatal Rats*. Endocrinology. 125(1). 478–485. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact